(Circulation. 2005;112:I-212 I-218.)
© 2005 American Heart Association, Inc.
Myocardial Protection and Vascular Biology |
From the Division of Cardiothoracic Surgery (S.L.G., H.S.M., J.B.B., M.R.M.), Washington University School of Medicine, St Louis, Mo; and the Department of Cardiology (P.S.), Leiden University Medical Center, the Netherlands.
Correspondence to Dr Marc R. Moon, Division of Cardiothoracic Surgery, Washington University School of Medicine, 3108 Queeny Tower, 1 Barnes-Jewish Plaza, St Louis, MO 63110-1013. E-mail moonm{at}msnotes.wustl.edu
| Abstract |
|---|
|
|
|---|
Methods and Results In 7 dogs, RA and RV pressure and volume (conductance catheter) were recorded at baseline and after 3 months of progressive pulmonary artery banding. RA and RV elastance (contractility) and diastolic stiffness were calculated, and RA reservoir and conduit function were quantified as RA inflow with the tricuspid valve closed versus open, respectively. With chronic pulmonary artery banding, systolic RV pressure increased from 34±7 to 70±17 mm Hg (P<0.001), but cardiac output did not change (P>0.78). RV elastance and stiffness both increased (P<0.05), suggesting preserved systolic function but impaired diastolic function. In response, RA contractility improved (elastance increased from 0.28±0.12 to 0.44±0.13 mm Hg/mL; P<0.04), and the atrium became more distensible, as evidenced by increased reservoir function (49±14% versus 72±8%) and decreased conduit function (51±14% versus 28±8%; P<0.002).
Conclusions With chronic RV pressure overload, RV systolic function was preserved, but diastolic function was impaired. To compensate, RA contractility increased, and the atrium became more distensible to maintain filling of the stiffened ventricle. This compensatory response of the right atrium likely plays an important role in preventing clinical failure in chronic pulmonary hypertension.
Key Words: atrium hypertension, pulmonary pulmonary heart disease
| Introduction |
|---|
|
|
|---|
Historically, the right atrium has been difficult to study because of its amorphous architecture and the complex interplay that occurs among the atrium, ventricle, and systemic and coronary venous circulation during both systole and diastole. Therefore, studies evaluating both normal and pathophysiologic RA mechanics are limited,812 and the impact of CPH on RA function remains unknown. If the right atrium is more sensitive to CPH than the ventricle, unfavorable changes in compliance may impair RV filling, but if the atrium is less sensitive than the ventricle, changes in compliance may be protective as the atrium compensates to maintain cardiac output. In an elegant computer model, Suga13 suggested that atrial distensibility may substantially influence cardiac performance, but our understanding of this relationship under pathologic conditions is limited. The purpose of the current investigation was to use conductance technology to study RA and RV function simultaneously during chronic RV pressure loading to determine the pathophysiologic sequelae of CPH that portend right heart failure.
| Methods |
|---|
|
|
|---|
A 7-Fr pressure catheter (Millar MPC-500) was advanced through the left mammary artery to the arch to record central aortic pressure. Ultrasonic flow probes (10- to 12-mm perivascular probes with a T206 Flowmeter, Transonic Systems) were placed around the superior (SVC) and inferior (IVC) vena cava
1 cm from the caval-atrial junction to measure RA inflow. A tourniquet was positioned around the IVC to allow transient caval occlusion (preload alteration during data collection). A 1-cm incision was made in the pericardium over the anterior RV free wall, and a 6-Fr combined pressure volume (PV) conductance catheter (Millar SPR-843) was introduced through a purse-string suture just below the pulmonary valve and positioned toward the apex.6 The RV catheter measured RV pressure (RVP) and RV chamber conductance using dual-field technology with 12 electrodes 4 mm apart. A second 1-cm incision was made in the pericardium over the RA appendage, and a 5-Fr combined PV conductance catheter (Millar SPR-766) was positioned along the long axis of the right atrium so that its tip rested at the RA-IVC junction.11 The RA catheter measured RA pressure (RAP) and RA chamber conductance using dual-field technology with 10 electrodes 4 mm apart. These catheters were connected to 2 signal conditioner processors (Sigma 5DF, CD Leycom) to convert instantaneous conductance measurements into RA and RV volume as described previously and summarized below.11,14,15
Baseline Data Acquisition
Baseline data were recorded during steady-state conditions with the pericardium intact. During each data acquisition run, ECG, RAP, RVP, aortic pressure, SVC flow, IVC flow, and RA and RV conductance signals were acquired at 200 Hz and processed using custom-designed computer software. The RAP and RVP signals were differentiated with respect to time to calculate instantaneous RA dP/dt and RV dP/dt. To minimize the effects of intrathoracic pressure variation, the respirator was temporarily interrupted at end expiration during data collection for 10 to 15 seconds. Initially, hypertonic saline (3 mL, 10% solution) was injected into the cephalic vein and PV loops recorded for 15 to 20 seconds to determine RA and RV parallel conductance and calibrate volume calculations (see below).14 Then, after steady-state data were obtained (3 to 5 beats), slow, progressive vena caval occlusion was performed to generate RA and RV PV loops over a wide physiological range of filling pressures. Data acquisition runs were repeated in triplicate, and all of the runs containing premature ventricular contractions were excluded from future analysis. Sufficient time was allowed between runs for hemodynamic stabilization (2 to 4 minutes).
Creation of Chronic RVP Overload
Following baseline data collection, the RA and RV PV catheters were removed, and a 5-Fr pressure catheter (Access Technologies) was introduced into the RV-free wall and secured in place. An inflatable silastic band (16-mm diameter, Access Technologies) was secured around the distal main pulmonary artery (PA). The PA band and RVP catheters were tunneled through the left and right lateral chest walls, respectively, and connected to small reservoirs covered with silicone membranes that allowed injection of saline and pressure monitoring. Each reservoir was buried in a subcutaneous pocket. The sternum was reapproximated with wires, and the overlying soft tissue was closed in layers after placing a 28-Fr chest tube for drainage.
Approximately 1 week after the baseline operation, when the animal was fully recovered, RVP overload was initiated in a stepwise manner with progressive inflation of the PA band via saline injection into its reservoir. With the animals resting comfortably, RVP was monitored by connecting its reservoir to a pressure transducer. Approximately 0.3 to 0.5 mL of saline was injected into the PA band reservoir to increase inflation. Inflation of the PA band was performed weekly, increasing RVP by 10 to 20 mm Hg at each inflation until near-systemic pressures were achieved.16,17 The RVP reservoir was flushed with heparinized saline to prevent clotting between inflation intervals.
Data Acquisition after Creation of Chronic RVP Overload
Animals underwent a second data acquisition study an average of 101±44 days after the initial baseline study. Animals were again anesthetized with propofol for induction (5 to 7 mg/kg IV) and intubated and ventilated using propofol for maintenance (0.5 mg/kg/min). A repeat median sternotomy was performed to access the heart. The pericardium was again left intact except for 2 small openings to allow placement of the RA and RV PV catheters. Hypertonic saline injection was again performed to determine RA and RV parallel conductance and calibrate volume measurements. Data were then collected as described above during steady-state conditions with slow IVC occlusion to alter preload and repeated in triplicate.
At the conclusion of the experiment, the animals were euthanized using sodium pentothal (1g IV) followed (after 2 minutes) by potassium chloride (80 meq IV), and proper positioning of the catheters was confirmed. All of the animals received humane care in compliance with the Principles of Laboratory Animal Care formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Sciences and published by the National Institutes of Health. The study was approved by the Washington University School of Medicine Animal Studies Committee and conducted according to Washington University policy.
Data Analysis
RA and RV Volume
Instantaneous RA and RV volumes were determined using the conductance catheter methods as described previously.11,14,15 Relative RA and RV volumes were converted into absolute RA and RV volumes by subtracting Vc, the parallel conductance factor, and multiplying by
, the conductance gain factor. The parallel conductance factor, Vc, which accounts for conductance of the surrounding structures, was calculated for both chambers using the PV loops created during injection of hypertonic saline. The conductance gain factor,
, was determined for the RV by comparing uncalibrated conductance catheter values to stroke volumes obtained by integrating RA inflow throughout the cardiac cycle. For the RA, stroke volumes were compared only during RA filling, when the tricuspid valve was closed. Changes in RA chamber volume do not equal RA inflow when the valve is open because of direct caval flow into the ventricle. Separate values were obtained for Vc and
during the baseline and chronic studies.
RA Elastance (Contractility)
RA contractile performance was assessed using the "atrial-end-systolic" pressure-volume relationship (RA-ESPVR, chamber elastance).18,19 Atrial-end-systolic pressure (RAPA-ES) and volume (RA-VolA-ES) points were determined for each cardiac cycle during preload reduction, and, by least-squares linear regression, a straight line was fitted to the following equation:
|
|
where EA-ES (mm Hg/mL) and V0 (mL) are the slope (RA chamber elastance) and volume-axis intercept, respectively.
RA Stiffness
Static RA stiffness was defined as the slope of the "atrial-end-diastolic" P-V relation. Atrial-end-diastolic pressure (RAPA-ED) and volume (RA-VolA-ED) points were determined at the time of maximum RA volume (corresponding to tricuspid valve opening and the RAP V-wave) for each cardiac cycle during preload reduction. By least-squares linear regression, a straight line was fitted to the following equation:20
|
|
where RA stiffness (mL/mm Hg) and VA-ED (mL) are the slope and RA diastolic equilibrium volume, respectively.
RV Elastance and Stiffness
Similar mathematical methods were used to calculate RV elastance and stiffness as the slope of the RV ESPVR and RV EDPVR as follows: equation
|
|
and equation
|
|
where end-systole was defined as the time of maximum RVP:RV volume ratio and end diastole as the time of maximum RV volume.21
RA Reservoir and Conduit Function
Reservoir and conduit function of the right atrium were calculated by integrating RA inflow (combined SVC and IVC flow) during RV systole (reservoir) and RV diastole (conduit).12,2224 Because the tricuspid valve is closed during RV systole, all of the blood that enters from the cavae during this period is reserved in the atrium. Thus, RA reservoir volume equals integrated RA inflow from the ECG R-wave to the time of maximum RA volume, which corresponds to the time of tricuspid valve opening.23 In contrast, RA conduit volume equals integrated RA inflow during RV filling when the tricuspid valve is open. Figure 1 illustrates typical RA inflow patterns obtained from 1 animal at baseline and with chronic RVP overload. Integrated RA inflow volume during the reservoir and conduit phases was divided by total RA inflow volume (stroke volume) to yield reservoir function and conduit function as a percentage of total RA inflow.
|
Statistical Analysis
All of the data are reported as mean ±SD. Hemodynamic data obtained during steady-state recording are reported as the average of 3 consecutive beats. Data obtained during baseline and with chronic RVP overload (PA banding) were compared using the Student t test. All of the statistical analyses were performed using SigmaStat 2.03 (SPSS Inc).
| Results |
|---|
|
|
|---|
|
Typical RV PV loops during baseline and with chronic PA banding are illustrated in Figure 2 (same animal as depicted in Figure 1). Overall, with PA banding, RV elastance (contractility) increased from 0.48±0.17 to 1.65±0.68 mm Hg/mL (P<0.004) without a significant change in RV V0 (P>0.41) (Table 2 and Figure 3). Similarly, RV stiffness rose from 0.12±0.04 to 0.26±0.16 mm Hg/mL (P<0.05) but RV VED did not change (P>0.43).
|
|
|
Typical RA PV loops during baseline and with chronic PA banding are illustrated in Figure 4 (same animal as depicted in Figures 1 and 2
). Overall, with PA banding, RA elastance (contractility) increased from 0.28±0.12 to 0.44±0.13 mm Hg/mL (P<0.04) without a significant change in RA V0 (P>0.72) (Table 3 and Figure 5). Unlike the ventricle, there was not a significant change in RA stiffness (P>0.63) or RA VED (P>0.17) with chronic PA banding.
|
|
|
Figure 1 illustrates typical changes in reservoir and conduit function with chronic PA banding. During RV systole, when the tricuspid valve was closed, RA inflow increased from 11±4 to 15±4 mL, corresponding with increased prominence of the RA inflow curve during the reservoir phase, but the change was not significant (P>0.24). However, during RV filling, when the tricuspid valve was open, RV inflow fell significantly from 11±4 to 5±4 mL (P<0.005), corresponding with flattening of the RA inflow curve during the conduit phase. Thus, with chronic PA banding, atrial distensibility increased as evidenced by a significant rise in reservoir function from 49±14% to 72±8% and a corresponding decline in conduit function from 51±14% to 28±8% (P<0.002) (Figure 6).
|
| Discussion |
|---|
|
|
|---|
Studies examining RV function during acute RVP overload consistently report no significant change in RV diastolic performance, despite a 2- to 3-fold rise in RV elastance.5,27 However, with chronic RVP overload, RV diastolic dysfunction with prolonged diastolic relaxation times and increased RV diastolic stiffness is the norm.3,4,7 This is consistent with the 117% rise in RV diastolic stiffness measured in the current report. It has been proposed that in the acute setting, contractility increases through homeometric autoregulation without effecting diastolic function.5,15 But in the chronic setting, although pressure-induced ventricular hypertrophy continues to support increased RV contractile force, its effects on diastolic compliance and function may be detrimental. Furthermore, the in-series impact of these potentially negative RV diastolic changes suggests that RV filling becomes more dependent on RA function as RVP overload persists. If the atrium does not respond, cardiac output will likely fall, and clinical failure will manifest.
Focusing specifically on the right atrium in an earlier report from our laboratory, we measured a 33% rise in RA elastance and a 45% rise in RA diastolic stiffness during acute RVP overload.11 In the current report, the RA compensatory response to chronic RVP overload again included an increase in RA contractility as was the case for the ventricle, but unlike the acute setting, there was no longer a significant rise in RA diastolic stiffness, with the atrium acting more as a reservoir than a conduit. In an elegant computer model, Suga13 found that increased atrial compliance improved cardiac performance and concluded that a "flexible atrium" (increased receptacle capabilities) could substantially improve global cardiac output.
Exploring the impact of various hemodynamic interventions on RA reservoir and conduit function, we previously found in normal hearts that cardiac output was inversely related to the conduit:reservoir ratio in normal hearts.12 An increase in the reservoir contribution was associated with a higher cardiac output. In our previous report with acute RVP overload, we noted only a modest 8% rise in reservoir function from 56% to 64%, which did not reach statistical significance (P=0.09).11 However, in the current study, there was a substantial 23% rise in reservoir function from 49% at baseline to 72% with chronic RVP overload, consistent with the increase in atrial distensibility that others predicted would have a positive impact on cardiac output.13,23,24,28,29 Future histologic and biochemical studies will be necessary to elucidate the structural remodeling and receptor changes that are responsible for the adaptive physiological RA changes that allow it to both increase its contractile force and alter its distensibility.
Consistent with previous reports,3,4,6,7 heart rate did not change with chronic RVP overload in the current investigation. In addition, others have demonstrated that gradual PA banding can produce RVP overload without activation of the sympathetic nervous system or systemic renin-angiotensin system.6,30 These findings suggest that sympathetic stimulation is not the mechanism responsible for enhanced RV systolic performance in this setting. Chen et al31 noted increased
1- and ß-adrenergic receptor density in dogs with pulmonary hypertension, both of which contribute significantly to the hypertrophic response of adult myocardium to stress and may, in part, play a role in the genesis of increased RV contractile force. In an attempt to pharmacologically manipulate the adrenergic response of the right ventricle to chronic pressure overload, Hon et al26 administered Clenbuterol, a selective ß2-adrenergic receptor agonist that has been shown to induce cardiac hypertrophy in rats,32 to sheep undergoing chronic PA banding. The Clenbuterol group demonstrated a 5-fold greater rise in RV elastance (212% increase over baseline) compared with control sheep that did not receive the drug during banding (43% increase over baseline). Hon et al,26 however, did not examine the effects of stimulated hypertrophy on RV diastolic properties nor its impact on the ability of the right atrium to become more distensible. Furthermore, despite the 5-fold increase in contractile force with Clenbuterol, there was no change in cardiac output in either group. It is possible that detrimental changes in the diastolic properties of the right ventricle and atrium could make pharmacologically stimulated hypertrophy less desirable long-term.
Proposed Mechanism
Little is known about the effects of chronic RVP overload on the right atrium and the pathophysiological changes that occur. In previous studies on the left atrium where left ventricular failure was induced by pacing, Hoit et al33 found that there was significant up-regulation of ß-myosin heavy chain (MHC) in the body of the left atrium in response to chronic pressure and volume overload. This isoform (ß-MHC) is associated with left atrial hypertrophy, increased atrial mechanical work, maintained force generation (maximum and end systolic elastance), and decreased velocity of left atrial contraction. In their study, they found that there was a transition from fast (
) to slow (ß) MHC isoform. It is believed that this was a physiologically important adaptation of the left atrium to pressure and volume overload.33 The pathological changes that occur in the hypertrophied ventricle have been well described. These changes include early diastolic dysfunction followed by systolic impairment, interstitial fibrosis, and down-regulation of calcium-handling proteins sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban. These proteins are important regulators of intracellular calcium homeostasis and have been implicated in ventricular dysfunction; specifically, diastolic relaxation and reduction in these proteins are associated with increases in calcium-transient times.34 The accumulation of fibrillar collagen in the extracellular space, myocyte hypertrophy, perivascular fibrosis resulting in myocardial stiffness, and, ultimately, ventricular dysfunction are likely a result of cardiac fibroblast growth and enhanced collagen synthesis.35 Laks et al36 demonstrated an increase in glycogen in the hypertrophied right ventricle of dogs that were subjected to chronic PA banding. It is perceivable that similar changes occur within the RA tissue but at a slower rate than that occurring within the right ventricle. Hence, the right atrium is able to compensate for the failing right ventricle.
In this study, we did not quantify the degree of RV or RA hypertrophy, and histological evaluation of the right ventricle and right atrium was not done. However, in a previous study, Hsieh et al16 used a similar model to ours to induce pulmonary hypertension in dogs. On histological examination of the RV outflow tract, they found that there were quantitatively similar degrees of mild-to-moderate myocyte hypertrophy and mild fibrosis in the endocardium, subendocardium, and interstitium in both acute and chronic heart failure dogs at sacrifice.16 It is reasonable to assume that similar changes may have occurred in our study.
Potential Limitations
In previous studies of RA dynamics in sheep, the coronary sinus was ligated to prevent coronary venous return during periods of data collection.11,12 This was well tolerated, because sheep possess a unique collateral vessel between the coronary sinus and hemiazygous vein that prevents coronary venous distension after ligation. Dogs do not possess such a collateral; therefore, we did not feel that coronary sinus ligation would be safe long-term. This may have caused a small but presumably consistent error in reservoir-to-conduit calculations. In the clinical setting, the mean duration from the onset of symptoms to establishing the diagnosis of CPH is
2 years.37 The 3 month period of pulmonary hypertension in our model was relatively short compared with that of the clinical scenario. A more prolonged exposure to pulmonary hypertension may have resulted in myocyte hypertrophy, collagen formation, and changes in capillary density, which could have additionally altered both RV and RA function.
In summary, this study demonstrated that chronic RVP overload resulted in an increase in RV contractility, thus preserving RV systolic function. However, RV diastolic dysfunction occurred, likely the consequence of ventricular hypertrophy and remodeling. As a compensatory response to increased RV diastolic stiffness, which surely made it more difficult for the ventricle to fill, RA contractility increased to support the active atrial contribution to RV filling (atrial kick), and the atrium acted more as a reservoir than a conduit. RA reservoir function increased, representing increased atrial distensibility, which is an adaptive response that previous investigators conclude would have a positive impact on global cardiac output.13,23,24,28,29 These compensatory changes in RA function likely play an important role in maintaining RV filling and preload to preserve cardiac output and prevent right heart failure during chronic RVP overload.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2. Rubin LJ. ACCP consensus statement. Primary pulmonary hypertension. Chest. 1993; 104: 236250.
3. Chen EP, Bittner HB, Tull F, Biswas SS, Davis RD, Van Trigt P. An adult canine model of chronic pulmonary hypertension for cardiopulmonary transplantation. J Heart Lung Transplant. 1997; 16: 538547.[Medline] [Order article via Infotrieve]
4. Chen EP, Craig DM, Bittner HB, Davis RD, Van Trigt P. Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. Circulation. 1998; 97: 16061612.
5. De Vroomen M, Cardozo RHL, Steendijk P, Van Bel F, Baan J. Improved contractile performance of right ventricle in response to increased RV afterload in newborn lamb. Am J Physiol Heart Circ Physiol. 2000; 278: H100H105.
6. Leeuwenburgh BPJ, Helbing WA, Steendijk P, Schoof PH, Baan J. Biventricular systolic function in young lambs subject to chronic systemic right ventricular pressure overload. Am J Physiol Heart Circ Physiol. 2001; 281: H2697H2704.
7. Leeuwenburgh BPJ, Steendijk P, Helbing WA, Baan J. Indexes of diastolic RV function. Load dependence and changes after chronic RV pressure overload in lambs. Am J Physiol Heart Circ Physiol. 2002; 282: H1350H1358.
8. Miller MJ, McKay RG, Ferguson JJ, Sahagian P, Nakao S, Come PC, Grossman W. Right atrial pressure-volume relationships in tricuspid regurgitation. Circulation. 1986; 73: 799808.
9. Carlson DE, Burchard KW, Gann DS. Right atrial volume during hemorrhage in the dog. Am J Physiol Heart Circ Physiol. 1986; 250: H1136H1144.
10. Ferguson JJ, Miller MJ, Aroesty JM, Sahagian P, Grossman W, McKay RG. Assessment of right atrial pressure-volume relations in patients with and without an atrial septal defect. J Am Coll Cardiol. 1989; 13: 630636.[Abstract]
11. Maniar HS, Prasad SM, Gaynor SL, Chu CM, Steendijk P, Moon MR. Impact of pericardial restraint on right atrial mechanics during acute right ventricular pressure load. Am J Physiol Heart Circ Physiol. 2003; 284: H350H357.
12. Gaynor SL, Maniar HS, Prasad SM, Steendijk P, Moon MR. Reservoir and conduit function of the right atrium. Impact on right ventricular filling and cardiac output. Am J Physiol Heart Circ Physiol. 2005; 288: H2140H2145.
13. Suga H. Importance of atrial compliance in cardiac performance. Circ Res. 1974; 35: 3943.
14. Steendijk P, Staal E, Jukema JW, Baan J. Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter. Am J Physiol Heart Circ Physiol. 2001; 281: H755H763.
15. De Vroomen M, Steendijk P, Cardozo RHL, Brouwers HA, Van Bel F, Baan J. Enhanced systolic function of the right ventricle during respiratory distress syndrome in newborn lambs. Am J Physiol Heart Circ Physiol. 2001; 280: H392H400.
16. Hsieh CM, Mishkel GJ, Cardoso PFG, Rakowski H, Dunn SC, Butany J, Weisel RD, Patterson GA, Cooper JD. Production and reversibility of RV hypertrophy and RHF in dogs. Ann Thorac Surg. 1992; 54: 104110.[Abstract]
17. Leeuwenburgh BP, Schoof PH, Steendijk P, Baan J, Mooi WJ, Helbing WA. Chronic and adjustable pulmonary artery banding. J Thorac Cardiovasc Surg. 2003; 125: 231237.
18. Alexander J, Sunagawa K, Chang N, Sagawa K. Instantaneous pressure-volume relation of the ejecting canine left atrium. Circ Res. 1987; 61: 209219.
19. Hoit BD, Shao Y, Gabel M, Walsh RA. In vivo assessment of left atrial contractile performance in normal and pathological conditions using a time-varying elastance model. Circulation. 1994; 89: 18291838.
20. Moon MR, DeAnda A, Castro LJ, Daughters GT, Ingels NB, Miller DC. Effects of mechanical LV support on RV diastolic function. J Heart Lung Tranplant. 1997; 16: 398407.[Medline] [Order article via Infotrieve]
21. Moon MR, Castro LJ, DeAnda A, Tomizawa Y, Daughters GT, Ingels NB, Miller DC. Right ventricular dynamics during LV assistance in closed-chest dogs. Ann Thorac Surg. 1993; 56: 5467, 1993.[Abstract]
22. Hoit BD, Shao Y, Gabel M, Walsh RA. Influence of pericardium on left atrial compliance and pulmonary venous flow. Am J Physiol Heart Circ Physiol. 1993; 264: H1781H1787.
23. Hoit BD, Shao Y, Tsai L, Patel R, Gabel M, Walsh RA. Altered left atrial compliance after atrial appendectomy. Influence on left atrial and ventricular filling. Circ Res. 1993; 72: 167175.
24. Nishikawa Y, Roberts JP, Tan P, Klopfenstein CE, Klopfenstein HS. Effect of dynamic exercise on left atrial function in conscious dogs. J Physiol. 1994; 481: 457468.
25. Assey ME, Wisenbaugh T, Spann JF, Gillette PC, Carabello BA. Unexpected persistence into adulthood of low wall stress in patients with congenital aortic stenosis. Is there a fundamental difference in the hypertrophic response to a pressure overload present from birth? Circulation. 1987; 75: 973979.
26. Hon JKF, Steendijk P, Petrou M, Wong K, Yacoub MH. Influence of clenbuterol treatment during six weeks of chronic right ventricular pressure overload as studied with pressure-volume analysis. J Thorac Cardiovasc Surg. 2001; 122: 767774.
27. Hon JKF, Steendijk P, Khan H, Wong K, Yacoub M. Acute effects of pulmonary artery banding in sheep on right ventricular pressure-volume relations. Relevance to the arterial switch operation. Acta Physiol Scand. 2001; 172: 97106.[CrossRef][Medline] [Order article via Infotrieve]
28. Tabata T, Oki T, Yamada H, Iuchi A, Ito S, Hori T, Kitagawa T, Kato I, Kitahata H, Oshita S. Role of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping during cardiac surgery. Am J Cardiol. 1998; 81: 327332.[CrossRef][Medline] [Order article via Infotrieve]
29. Barbier P, Solomon SB, Schiller NB, Glantz SA. Left atrial relaxation and left ventricular systolic function determine left atrial reservoir function. Circulation. 1999; 100: 427436.
30. Koide M, Carabello BA, Conrad CC, Buckley JM, DeFreyte G, Barnes M, Tomanek RJ, Wei CC, DellItalia LJ, Cooper G, Zile MR. Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation. Am J Physiol Heart Circ Physiol. 1999; 276: H350H358.
31. Chen EP, Akhter SA, Bittner HB, Koch WJ, Davis RD, Van Trigt P. Molecular and functional mechanisms of right ventricular adaptation in chronic pulmonary hypertension. Ann Thorac Surg. 1999; 67: 10531058.
32. Petrou M, Wynne DG, Boheler KR, Yacoub M. Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. Circulation. 1995; 92 (suppl II): II483II489.
33. Hoit BD, Shao Y, Gabel M, Walsh RA. Left atrial mechanical and biochemical adaptation to pacing induced heart failure. Cardiovasc Res. 1995; 29: 469474.[CrossRef][Medline] [Order article via Infotrieve]
34. Wong K, Boheler KR, Petrou M, Yacoub MH. Pharmacological modulation of pressure-overload cardiac hypertrophy. Circulation. 1997; 96: 22392246.
35. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991; 83: 18491865.
36. Laks MM, Van De Velde S, Swan HJC. The presence and location of glycogen in the hypertrophied right ventricle of the canine heart. Cardiovasc Res. 1969; 3: 272276.
37. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997; 336: 111117.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |